Submit your research
Start your submission and get more impact for your research by publishing with us.
- Frontiers in Cardiovascular Medicine
- Lipids in Cardiovascular Disease
Author guidelines
Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.
Editor guidelines
Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.
Peer review
Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.
Publishing fees
Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.
Journal notices
Submission closing: Specialty Chief Editor's Collection on Non-Invasive Cardiovascular Imaging
Submissions close 30 May 2026—last call to join the collection curated by Sebastian Kelle, our Specialty Chief Editor for Cardiovascular Imaging, spanning AI diagnostics, genetics, cardiomyopathies, heart failure, and prevention
Polyvascular Imaging for Cardiovascular Risk Prediction
Submit your work on polyvascular imaging across multiple arterial beds—combining carotid, coronary, femoral, and aortic imaging with AI and biomarkers for enhanced cardiovascular risk prediction. Deadline 15 October 2026.
Reimagining cardiac rehabilitation: lessons from history for a post‑MI future
Explore how cardiac rehabilitation evolved from strict bed rest to modern post‑MI care. Julie Redfern (University of Sydney) and Tom Briffa (University of Western Australia) trace its history and outline how programs must modernize for today’s patients
eBook of the month
Calcification is no longer a bystander. This eBook maps cardiovascular calcification across its clinical phenotypes—from coronary arteries to heart valves—and highlights emerging diagnostic tools and therapeutic targets.
When loop diuretics stop working: how to fight back against diuretic resistance
One in three heart failure patients fails to decongests despite aggressive diuretics. This review unpacks the mechanisms — from tubular adaptation to chloride depletion — and maps a phenotype-tailored playbook for cardiorenal syndrome.
Editors
See allchieko mineo
University of Texas Southwestern Medical Center
Dallas, United States
Specialty Chief Editor
Lipids in Cardiovascular Disease
catherine j. andersen
University of Connecticut
Storrs, United States
Associate Editor
Lipids in Cardiovascular Disease
yvonne baumer
National Heart, Lung, and Blood Institute (NIH)
Bethesda, United States
Associate Editor
Lipids in Cardiovascular Disease
christopher blesso
University of Connecticut
Storrs, United States
Associate Editor
Lipids in Cardiovascular Disease
